Agile Therapeutics, President and Chief Executive Officer
Al Altomari is the President and Chief Executive Officer of Agile Therapeutics and a member of the Company’s Board of Directors. Prior to being named President and CEO, Mr. Altomari served as Agile’s Executive Chairman in which capacity he closed a $45 million venture round in May 2010.
Head of the North America R&D Hub and Vice President of Disposition, Safety and Animal Research Scientific Core Platform, Sanofi
Marc Bonnefoi is Head of the North America R&D Hub and Vice President, Disposition, Safety and Animal Research (DSAR) Scientific Core Platform. In this role, he oversees all R&D activities in North America, including the Sanofi Boston R&D Hub, Tucson Research Center, Sanofi Pasteur R&D, the Genzyme San Antonio R&D site, Canadian Clinical Study Unit, Merial R&D and the North America Development Center.
Amicus Therapeutics, Inc., Chairman and Chief Executive Officer
John F. Crowley is the Chairman and CEO of Amicus Therapeutics, Inc. John’s involvement with biotechnology stems from the 1998 diagnosis of two of his children with Pompe disease-a severe and often fatal neuromuscular disorder.
Johnson & Johnson/Janssen Biotech, Vice President, Immunology Marketing
John began his career with Johnson & Johnson 21 years ago and has enjoyed a broad and diverse career holding various sales and marketing leadership positions across the Johnson & Johnson family of companies.
Chromocell Corporation, Chief Executive Officer
Christian co-founded Chromocell in 2002, serving initially as General Counsel before becoming Chief Executive Officer in 2005.
Insmed Incorporated; President and Chief Executive Officer
Will joined Insmed in September 2012 as President and Chief Executive Officer and as a member of the Board of Directors. Read more »
Vicus Therapeutics, President and Chief Executive Officer
John Maki previously served as Managing Director of Technology Directors, Inc., as Managing Director of Audax Group and as Principal, Bain Capital, as well as consultant, Bain & Company.
Celldex Therapeutics, Inc., Founder, President, Chief Executive Officer and Director
Mr. Marucci is a Founder of Celldex and served as its Vice President, Chief Financial Officer, Treasurer and Secretary since inception and prior to his appointments to Executive Vice President in March 2008, President and Chief Executive Officer in October 2008, and the Board of Directors in December 2008. Read more »
CardioVax Inc., Chief Executive Officer
Dr. Olukotun is the Chief Executive Officer of CardioVax Inc., a biotechnology company focused on developing innovative cardiovascular therapies. Read more »
PTC Therapeutics, Inc., Chief Executive Officer
Stuart W. Peltz, Ph.D. is a co-founder of PTC, member of the board of directors and Chief Executive Officer since the company’s inception in 1998. Read more »
Cyclacel Pharmaceuticals, Inc., President & Chief Executive Officer
Mr. Rombotis joined Cyclacel as its first CEO in 1997 and has 30 years of experience with biopharmaceutical companies. Read more »
Drais Pharmaceuticals Inc., President and Chief Executive Officer
Dr. Tempel is President, Chief Executive Officer and co-founder of Drais Pharmaceuticals Inc. Drais is a venture-capital supported clinical drug development company, based in Bridgewater, New Jersey. Read more »
Celgene Coporation, Corporate Vice President and General Manager, US Hematology and Oncology
Shawn Tomasello currently serves as Corporate Vice President and General Manager, US Hematology and Oncology for Celgene Corporation, Summit, NJ.
